Tumour rejection antigens

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8519109
APP PUB NO 20090209034A1
SERIAL NO

12364746

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Polypeptides comprising an unbroken sequence of amino acids from SEQ. ID. NO. 1 or 2, with an ability to complex with a major histocompatibility complex molecule type HLA-A2, and preferably HLA-A2.1.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LUDWIG INSTITUTE FOR CANCER RESEARCH LTD605 THIRD AVENUE NEW YORK NY 10158

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boon-Falleur, Thierry Brussels, BE 156 1105
Brasseur, Francis Brussels, BE 16 63
De, Plaen Etienne Brussels, BE 26 551
Huang, Lan-Qing Baltimore, US 2 3
van, Pel Aline Brussels, BE 19 306

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation